To add the clinical relevance, we first analyzed the protein expression of ACE2, phosphorylated-SHP2 (p-SHP2), and HIF1α by IHC in a cohort of 202 HCC patients. This evidence concerns the gene PTPN11 and hepatocellular carcinoma.